medigraphic.com
Órgano de Difusión de la Asociación Académica Panamericana de Medicina Familiar A.C.

2024, Number 6

<< Back Next >>

Arch Med Fam 2024; 26 (6)

Detection of Symptoms Related to Anxiety, Depression, and Stress in Patients with HIV using the DASS-21 SCALE

Robinson RGE, de León AM, Domínguez MA, Haro AME, Ayala FRI, Soria RCG

Language: Spanish
References: 17
Page: 287-291
PDF size: 189.19 Kb.


ABSTRACT

Objective: To Detect symptoms related to anxiety, depression and stress in patients with HIV using the DASS-21 scale. Methods: Cross-sectional study in patients with HIV who came to receive care at Family Medicine Unit N0 16, applying the DASS-21 scale to detect depression, anxiety, and stress. From the census of 66 patients, five patients were excluded for not agreeing to participate and two for being minors, leaving 59 patients. Descriptive statistics were obtained using the statistical program SPSS v22. Results: The predominant age was 40.13 ± 13.125 years, male sex, and high school level. 71.2% presented stress, 64.4% anxiety, and 35% depression. Such disorders were more frequent in women (83.3% stress and anxiety, and 50% depression). Regarding the symptoms associated with depression, anxiety, and stress, the most observed were "I felt sad and depressed", "I was worried about situations in which I could panic or in which I could make a fool of myself" and "I had a hard time relaxing", appearing in 62.71%, 69.49 % and 91.53 % respectively. Conclusions: The frequency of depression, anxiety and stress was high in both sexes. These disorders should be taken into account at primary care.


REFERENCES

  1. ONUSIDA. [Internet]. Hoja Informativa. Últimas estadísticassobre el estado de la epidemia de SIDA. 2021[acceso 22/04/2022citado 2022 abril 22]. Disponible:https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_es.pdf

  2. Secretaría de Salud. Sistema de Vigilancia epidemiológicade VIH, 4to trimestre 2021. [acceso22/04/2022]. Disponible:

  3. https://www.gob.mx/cms/uploads/attachment/file/710892/VIH-SIDA_4totrim_2021.pdf

  4. Remien RH, Stirratt MJ, Nguen N, Robbins RN, PalaAN, Mellins CA. Mental health and HIV/AIDS: the needfor an integrated response. AIDS. 2019; 33(9):1411-1420. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635049

  5. Bhana A, Kreniske P, Pather A, Abas MA, Mellins CA.Interventions to address the mental health of adolescentsand young adults living with or affected by HIV:state of the evidence. J Int AIDS Soc. 2021;4(Suppl 2):e25713. https://doi.org/10.1002/jia2.25713

  6. Chong ML, Fong JY, Dhevann R, Wong PL, Anjanna K,Sharifah FSO, et al. A retrospective analysis of the carecascades for non-communicable disease and mentalhealth among people living with HIV at a tertiary-carecentre in Malaysia: opportunities to identify gaps andoptimize care. J Int AIDS Soc. 2020;23(11): e25638. https://doi.org/10.1002/jia2.25638

  7. Akhtar B, Muyu L, Xiao CZ, Jürgen M. Psychometricproperties and measurement invariance of Depression,Anxiety and Stress Scales (DASS-21) across cultures.IJP. 2020;55(6): 916-925. https://onlinelibrary.wiley.com/doi/full/10.1002/ijop.12671

  8. Coker AO, Coker OO, Sanni D. Psychometric propertiesof the 21-item Depression Anxiety Stress Scale (DASS-21). AFRREV 2018; 12(2):135-142. https://www.ajol.info/index.php/afrrev/article/view/174532

  9. Camara A, Sow MS, Touré A, Sako FB, Camara I, SoumaoroK, et al. Anxiety and depression among HIVpatients of the infectious disease department of ConakryUniversity Hospital in 2018. Epidemiol Infect.2018;148: e8. doi: 10.1017/S095026881900222X.

  10. Cardona-Duque DV, Medina-Pérez OA, Herrera CastañoSM, Orozco Gómez PA. Depresión y factores asociadosen personas viviendo con VIH/Sida en Quindío, Colombia,2015. Rev Haban Cienc Méd. 2016;15(6) 941-954.http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1729519X2016000600010&lng=es.

  11. Organización Panamericana de la Salud. [Internet]La pandemia por COVID-19 provoca un aumento del25% en la prevalencia de la ansiedad y la depresiónen todo el mundo. Nota descriptiva 2 Mar 2022. [acceso14/07/2022]. Disponible:https://www.paho.org/es/noticias/2-3-2022-pandemia-por-covid-19-provoca-aumento-25-prevalencia-ansiedad-depresion-todo

  12. Prince Torres A. Afectaciones psicológicas de los pacientescon VIH/Sida en tiempos de pandemia. INVESTIGATIO.2022;(18):105-121. https://doi.org/10.31095/investigatio.2022.18.6

  13. Retana ADL. Factores de incidencia sobre el padecimientode depresión en la población mexicana. RMIP.2021;13(1):61-74. https://doi.org/10.32870/rmip.v13i1.408

  14. Saadat M, Behboodi ZM, Saadat E. Comparison of depression,anxiety, stress, and related factors amongwomen and men with human immunodeficiency virusinfection. J Hum Reprod Sci. 2015;8(1):48-51. https://doi.org/10.4103/0974-1208.153128

  15. Obermeyer CM. HIV in the Middle East.BMJ. 2006;333(7573):851-854. doi: 10.1136/bmj.38994.400370.7C.

  16. Préta LH, Chroboczek T, Treluyer JM, Chouchana L.Association of depression and suicidal behaviourreporting with HIV integrase inhibitors: a globalpharmacovigilance study. J Antimicrob Chemother.2023;78(8):1944-1947. https://doi.org/10.1093/jac/dkad187

  17. Tapullima-Mori C. Factores relacionados con la ansiedady depresión en pacientes con VIH de un hospitalpúblico. Rev Investig Psicol 2022;25(2):55-71. https://doi.org/10.15381/rinvp.v25i2.21424




2020     |     www.medigraphic.com